Haiqing Chen
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Simplified perioperative serplulimab and chemotherapy for resectable squamous NSCLC: a phase II trial with biomarker analysis.
Journal: Journal for immunotherapy of cancer
Published: April 26, 2026
GNL3L-LMNB1 signaling axis promotes lung squamous cell carcinoma growth and ferroptosis resistance via NF-κB activation.
Journal: Journal of thoracic disease
Published: March 09, 2026
HADHA promotes esophageal cancer progression by activating mTOR signaling and the SP1/MDM2 axis.
Journal: Acta biochimica et biophysica Sinica
Published: September 27, 2024
Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stages.
Journal: Nature communications
Published: September 12, 2023
Pattern of tumor regression after neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma.
Journal: Journal of thoracic disease
Published: May 31, 2023
The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types.
Journal: Frontiers in oncology
Published: December 22, 2020
Characterization of gene expression profiles of esophageal cancer patients with different nonsynonymous tumor mutation burden.
Journal: Thoracic cancer
Published: March 06, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026